DHS found guilty of fake attempt to bring an antibiotic from India to market
The Ninth Arbitration Court of Appeal in Moscow found the Ministry of Health guilty of attempting to introduce an Indian antibiotic to the Russian market using false documents. Izvestia has familiarized itself with its decision.
In February 2024, the Indian company Copran Research Laboratories Limited, which produces pharmaceutical ingredients and finished dosage forms, filed a lawsuit against the Russian Ministry of Health in the Moscow Arbitration Court. In it, it claimed infringement of patent rights for the use of its substance for the drug Biapenem. In its lawsuit, the company demanded to cancel the registration of the drug in Russia.
The holder of the registration certificate was Jodas Expoim, the Russian legal entity of another Indian pharma company, JODAS Expoim Pvt. Ltd. Ltd. "In its lawsuit, Copran Research claimed that JODAS representatives forged their written consent to use the active ingredient they produced. It should have been contained in Biapenem (the document is at the disposal of Izvestia). In June 2024, the Arbitration Court concluded that the claimed claims were not subject to satisfaction. As a result, the decision of the court of first instance was reversed and recognized the inaction of the Ministry of Health as illegal.
The court ruling noted that the agency had failed to take action to suspend and cancel the state registration of the drug Biapenem, despite the fact that Jodas Expoim had provided false documents and information about the active pharmaceutical substance and its manufacturer.
Read more in the exclusive material of Izvestia:
Переведено сервисом «Яндекс Переводчик»
